BayWa’s Countdown to Autumn: Three Conditions, One Debt Write-Off, and a Mounting Legal Battle

BayWa faces a make-or-break autumn with three simultaneous deadlines to close a €2.7 billion financing gap, while T&G sale and shareholder lawsuits add pressure.

The next few months will determine whether BayWa’s restructuring plan is a realistic path out of crisis or merely a holding pattern. The troubled agricultural conglomerate is due to publish its first-quarter update on 26 May, giving investors a preliminary look at whether the cost-cutting measures are having any effect. But the real test comes in autumn, when three separate deadlines must be met simultaneously for the turnaround to remain legally viable.

Investors are already voting with their feet. The stock trades at €13.05, down more than 22% since the start of the year and nearly 28% lower than 12 months ago. From its 52-week high, the share price has shed more than 39%. With annualised volatility exceeding 90%, this is not a garden-variety recovery story.

The €2.7 Billion Hole at the Heart of the Rescue

At the core of BayWa’s restructuring is a financing gap of €2.7 billion. To close it, the company must deliver on three fronts by the autumn of 2026: a fully audited annual report for the 2025 financial year, a binding extension of the standstill agreement with DZ Bank and UniCredit/HVB, and the sale of its New Zealand fruit subsidiary T&G Global. If any one of those pieces falls through, the entire StaRUG?based restructuring plan—finalised in May 2025—loses its legal foundation.

The audited accounts are not expected until the fourth quarter of 2026, meaning fundamental valuation will remain opaque until then. A new concept is supposed to be in place by mid?2026, and it will almost certainly require a debt haircut. Sources close to the process indicate that creditors would need to forgive claims totalling roughly €1 billion.

T&G Sale: Progress but No Breakthrough

The most tangible asset in the restructuring is BayWa’s 74% stake in T&G Global, the New Zealand?based marketer of apple brands such as Envy and Jazz. Goldman Sachs has been running a sale process since March 2026, with agricultural private?equity firms Roc Partners, Paine Schwartz and Hancock said to be circling. T&G generated $1.3 billion in revenue in 2024 and returned to profit with a net income of $16 million. The expected sale price is around €300 million—a meaningful contribution, but hardly a silver bullet given the scale of the broader deficit.

Complicating matters, Hong Kong?based Joy Wing Mau Group holds roughly a fifth of T&G’s shares and is resisting a majority takeover. That resistance has slowed the process and could depress the final price.

Legal Storms Converge

Parallel to the operational and financial challenges, legal pressure is building from multiple directions. The law firm TILP is preparing damages claims on behalf of shareholders who bought BayWa shares between January 2022 and January 2026. The claims are grounded in a BaFin ruling that found the company omitted details about a billion?euro loan and the risks attached to a €500 million bond in its 2023 management report. The suits target BayWa, former board members and auditor PwC.

Separately, the Munich public prosecutor’s office is investigating former chief executives Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and false representation in the 2023 annual accounts. The audit oversight body Apas is also scrutinising PwC, which issued an unqualified audit opinion for that year. All parties are presumed innocent until proven otherwise.

Shrinking to Survive

On the operational side, BayWa is pressing ahead with a drastic downsizing. By the end of 2028, the group plans to focus on four core business areas, cut roughly 1,300 jobs and reduce annual revenue to about €10 billion. No formal forecast for 2026 has been issued; the adjusted EBITDA target of around €140 million is only set for 2027.

Internally, oversight has been tightened. The threshold for board transactions that require supervisory?board approval has been lowered from €200 million to €50 million. Board member Marlen Wienert has stated that liquidity has reached its highest level since the crisis began, in line with the company’s internal projections.

The 26 May quarterly report will show whether that liquidity is translating into operational improvement. The autumn deadlines for the audited accounts, the bank extension and the T&G sale will decide whether the liquidity proves to be a bridge to recovery or merely a pause before the next crisis.